BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vacc...(s the key provider of global central lab...),Health

Rudi Marien, CEO of BARC group said, "This alliance emphasizes the growing strength of BARC in continents other than in the U.S. and Europe. It also confirms that BARC has grown into a highly recognized provider of biobanking services, given its ability to manage millions of patient samples for major international clinical trials."

For more information, please contact

BARC:

BARC South Africa,

Dr. Jessica Trusler, Medical Director

Tel +27 11 358 07 47

BARC USA,

Mr. Scott Keddy, Sr. Director Business Development

Tel: +1 516 719 1052

BARC Europe,

Dr. Guy Dewil, COO

Tel + 329 329 2 327

BARC is an independent global central laboratory, with subsidiaries in USA, Europe, South Africa, Australia, China, as well as a network of laboratories Asia and South America. BARC supports the pharmaceutical and biotechnology industry in the development and approval of new therapeutic agents by managing the laboratory component of clinical trials. BARC is committed to providing central laboratory services, including biobanking, that meet the highest quality standards, with rapid delivery of laboratory data. Worldwide testing is performed on equivalent instrumentation and integrated into a single global database with identical reference ranges and report.

BARC South Africa Pty., Ltd., established in 1999, is the South African arm of BARC, The local head office is in Johannesburg, with branch offices in Durban, Pretoria and Cape Town. BARC S.A. is a joint venture between BARC and LANCET LABORATORIES the foremost independent clinical pathology laboratory in South Africa. LANCET LABORATORIES brings a wealth of local knowledge to the joint venture, having provided a pathology service to the medical community since 1952. The joint venture allows for provision of LANCET LABO
'/>"/>